Clinical Trial Update: AD01 Follow up Extension Visit

View source ↗

Summary

Follow-up extension visit update for the AD01 Alzheimer's disease trial; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AD01

Snippet

Sponsor: Affiris AG | Conditions: Alzheimer´s Disease | Status: COMPLETED